Pain physicians across three countries found that standard ICD-10 substance dependence criteria have poor face validity when applied to patients prescribed cannabis-based medicines for chronic pain.
Pain medicine specialists, addiction psychiatrists, medical cannabis patients, and diagnostic criteria developers.
3-country surveyPhysicians in Canada, Germany, and Israel found ICD-10 dependence criteria poorly applicable to prescribed cannabis patients
What the researchers found
Physicians in Canada, Germany, and Israel reported that many ICD-10 cannabis dependence criteria (such as tolerance and withdrawal) do not accurately apply to patients using prescribed cannabis-based medicines for chronic pain, suggesting current diagnostic tools may pathologize legitimate medical use.
Why it matters
Applying addiction criteria designed for recreational use to medical cannabis patients could lead to misdiagnosis, stigma, and barriers to accessing effective pain treatment.
The numbers in context
Physicians from three countries (Canada, Germany, Israel) were surveyed on the face validity of ICD-10 criteria for cannabis dependence in prescribed patients.
How the study worked
International survey of pain medicine physicians assessing face validity of ICD-10 substance abuse and dependence criteria for medical cannabis patients.
Who was studied
Pain medicine physicians in Canada, Germany, and Israel treating patients with cannabis-based medicines.
What this study cannot tell us
Physician perceptions may differ from patient experiences; survey methodology introduces response bias; small sample across three countries may not represent all clinical perspectives.
How to read the evidence
Physician survey on diagnostic face validity; provides expert perspectives but not patient outcome data.
When this study was published
Recent study addressing an increasingly relevant diagnostic challenge.
The bigger picture
This study highlights a fundamental tension in how we define substance dependence: criteria developed for recreational drug use may not appropriately apply to prescribed medications, potentially requiring updated diagnostic frameworks.
Replication
Novel assessment of diagnostic validity in a specific clinical context; contributes to broader debate on medical cannabis and dependence.
Funding
Not specified
Conflicts of interest
Not specified
Questions still open
- Should separate diagnostic criteria exist for medical cannabis dependence?
- How do dependence rates in medical cannabis compare to other prescribed analgesics?
- Would revised criteria change clinical decision-making?
Read the original research
Face validity of the ICD-10 criteria of substance abuse and dependence for patients prescribed cannabis-based medicines for chronic pain-A survey of pain medicine physicians in Canada, Germany and Israel.
European journal of pain (London, England), 27(5), 588-601
Citation
Lauff, Sören; Petzke, Frank; Brill, Silviu; Schouten, Leonie; Fitzcharles, Mary-Ann; Pereira, John X; Häuser, Winfried. (2023). Face validity of the ICD-10 criteria of substance abuse and dependence for patients prescribed cannabis-based medicines for chronic pain-A survey of pain medicine physicians in Canada, Germany and Israel.. European journal of pain (London, England), 27(5), 588-601. https://doi.org/10.1002/ejp.2082